U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07386171) titled 'Micro-Ultrasound for Detecting Clinically Significant Prostate Cancer in Active Surveillance' on Jan. 27.
Brief Summary: Active surveillance is a common approach for men with low-risk or favorable intermediate-risk prostate cancer, aimed at avoiding or delaying treatment while closely monitoring the disease. Multiparametric MRI (mpMRI) is widely used to guide diagnosis and follow-up, but it can miss clinically significant prostate cancer and may be limited by access, cost, and variability in interpretation.
Micro-ultrasound is a high-resolution ultrasound technique that may improve real-time detection of suspicious prostate lesions ...